Trends in Candida central line-associated bloodstream infections among NICUs, 1999-2009

Pediatrics

Volumn 130, Issue 1, 2012, Pages

  Chitnis, Amit S ^a,b   Magill, Shelley S ^a   Edwards, Jonathan R ^a   Chiller, Tom M ^a   Fridkin, Scott K ^a   Lessa, Fernanda C ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Candida; Central line associated bloodstream infections; Epidemiology; Health care associated infection; Incidence; NICU

Indexed keywords

ARTICLE; CANDIDA ALBICANS; CATHETER INFECTION; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; FUNGUS IDENTIFICATION; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFANT; INVASIVE CANDIDIASIS; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN INTENSIVE CARE; NEWBORN MONITORING; PRIORITY JOURNAL; TREND STUDY; UMBILICAL ARTERY CATHETERIZATION;

EID: 84863532615     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2011-3620     Document Type: Article

References (32)

1. Stover BH, Shulman ST, Bratcher DF, Brady MT, Levine GL, Jarvis WR; Pediatric Prevention Network. Nosocomial infection rates in US children's hospitals' neonatal and pediatric intensive care units. Am J Infect Control. 2001;29(3):152-157 (Pubitemid 32507079)
2. Dudeck MA, Horan TC, Peterson KD, et al. National Healthcare Safety Network (NHSN) report, data summary for 2009, deviceassociated module. Available at: www.cdc.gov/nhsn/PDFs/dataStat/2010NHSNReport.pdf. Accessed December 5, 2011
3. Hocevar S, Horan T, Morrell G, Iwamato M, Edwards J, Lessa F. Rates and pathogen profile of device-associated infections among neonatal intensive care unit patients: data from the National Healthcare Safety Network, 2006-2008. In: Proceedings from The Society for Healthcare Epidemiology of America Fifth Decennial Meeting; March 18-22, 2010; Atlanta, GA
4. Schulman J, Stricof R, Stevens TP, et al New York State Regional Perinatal Care Centers. Statewide NICU central-line-associated bloodstream infection rates decline after bundles and checklists. Pediatrics. 2011;127(3):436-444
5. Wirtschafter DD, Pettit J, Kurtin P, et al. A statewide quality improvement collaborative to reduce neonatal central lineassociated blood stream infections. J Perinatol. 2010;30(3):170-181
6. Bizzarro MJ, Sabo B, Noonan M, Bonfiglio MP, Northrup V, Diefenbach K; Central Venous Catheter Initiative Committee. A quality improvement initiative to reduce central line-associated bloodstream infections in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 2010;31(3):241-248
7. Aly H, Herson V, Duncan A, et al. Is bloodstream infection preventable among premature infants? A tale of two cities. Pediatrics. 2005;115(6):1513-1518 (Pubitemid 43843158)
8. Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Donowitz LG. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med. 2001;345(23):1660-1666 (Pubitemid 33126821)
9. Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Grossman LB. Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight. J Pediatr. 2005;147(2):172-179 (Pubitemid 41207829)
10. Manzoni P, Stolfi I, Pugni L, et al. A multicenter, randomized trial of prophylactic fluconazole in preterm infants. N Engl J Med. 2007;356(24):2483- 2495 (Pubitemid 46919774)
11. Parikh TB, Nanavati RN, Patankar CV, et al. Fluconazole prophylaxis against fungal colonization and invasive fungal infection in very low birth weight infants. Indian Pediatr. 2007;44(11):830-837
12. Aydemir C, Oguz SS, Dizdar EA, et al. Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants. Arch Dis Child Fetal Neonatal Ed. 2011;96(3):F164-F168
13. Emori TG, Culver DH, Horan TC, et al. National nosocomial infections surveillance system (NNIS): description of surveillance methods. Am J Infect Control. 1991;19(1):19-35
14. Centers for Disease Control and Prevention. NHSN patient safety manual. Available at: www.cdc.gov/nhsn/TOC-PSCManual.html. Accessed December 5, 2011
15. Stark AR; American Academy of Pediatrics Committee on Fetus and Newborn. Levels of neonatal care. Pediatrics. 2004;114(5):1341-1347
16. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16(3):128-140
17. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309-332 (Pubitemid 351763841)
18. Centers for Disease Control and Prevention (CDC). Vital signs: central line-associated blood stream infections-United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep. 2011;60(8):243-248
19. Healy CM, Baker CJ, Zaccaria E, Campbell JR. Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit. J Pediatr. 2005;147(2):166-171 (Pubitemid 41207828)
20. Bertini G, Perugi S, Dani C, Filippi L, Pratesi S, Rubaltelli FF. Fluconazole prophylaxis prevents invasive fungal infection in highrisk, very low birth weight infants. J Pediatr. 2005;147(2):162-165 (Pubitemid 41207827)
21. Dutta S, Murki S, Varma S, Narang A, Chakrabarti A. Effects of cessation of a policy of neonatal fluconazole prophylaxis on fungal resurgence. Indian Pediatr. 2005;42(12):1226-1230 (Pubitemid 43243954)
22. Manzoni P, Arisio R, Mostert M, et al. Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study. Pediatrics. 2006;117(1). Available at: www.pediatrics.org/cgi/content/full/117/ 1/e22
23. Uko S, Soghier LM, Vega M, et al. Targeted short-term fluconazole prophylaxis among very low birth weight and extremely low birth weight infants. Pediatrics. 2006;117(4):1243-1252 (Pubitemid 46071518)
24. Aghai ZH, Mudduluru M, Nakhla TA, et al. Fluconazole prophylaxis in extremely low birth weight infants: association with cholestasis. J Perinatol. 2006;26(9):550-555 (Pubitemid 44305065)
25. McCrossan BA, McHenry E, O'Neill F, Ong G, Sweet DG. Selective fluconazole prophylaxis in high-risk babies to reduce invasive fungal infection. Arch Dis Child Fetal Neonatal Ed. 2007;92(6):F454-F458 (Pubitemid 350044002)
26. Healy CM, Campbell JR, Zaccaria E, Baker CJ. Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species. Pediatrics. 2008;121(4):703-710
27. Weitkamp JH, Ozdas A, LaFleur B, Potts AL. Fluconazole prophylaxis for prevention of invasive fungal infections in targeted highest risk preterm infants limits drug exposure. J Perinatol. 2008;28(6):405-411 (Pubitemid 351780934)
28. Aziz M, Patel AL, Losavio J, et al. Efficacy of fluconazole prophylaxis for prevention of invasive fungal infection in extremely low birth weight infants. Pediatr Infect Dis J. 2010;29(4):352-356
29. Burwell LA, Kaufman D, Blakely J, Stoll BJ, Fridkin SK. Antifungal prophylaxis to prevent neonatal candidiasis: a survey of perinatal physician practices. Pediatrics. 2006;118(4). Available at: www.pediatrics.org/cgi/ content/full/118/4/e1019
30. Pappas PG, Kauffman CA, Andes D, et al Infectious Diseases Society of America. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(5):503-535
31. Kaufman DA, Manzoni P. Strategies to prevent invasive candidal infection in extremely preterm infants. Clin Perinatol. 2010;37(3):611-628
32. Lessa F, Edwards JR, Horan TC, Kupronis B, Fridkin SK. Trends in incidence of methicillinresistance Staphylococcus aureus central line-associated bloodstream infections in U.S. neonatal intensive care units, 1998-2008. In: Proceedings of The Society for Healthcare Epidemiology of America Fifth Decennial Meeting; March 18-22, 2010; Atlanta, GA